Seeing Is Believing
Singular Genomics Systems's activity chart (see below) currently has 8 price targets and 13 ratings on display.
Analysts average stock forecasts to be materialized ratio is 34% with an average time for these price targets to be met of 35 days.
Most recent stock forecast was given by MATTHEW SYKES from GOLDMAN SACHS on 09-Jul-2024. First documented stock forecast 21-Jun-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Nov-2022
$6.5
2 years 25 days ago
(09-Jul-2024)
3/6 (50%)
$-1.15 (-15.03%)
73
Hold Since 06-Mar-2023
$12
2 years 4 months 15 days ago
(20-Mar-2024)
1/5 (20%)
$0.9 (8.11%)
26
Sell Since 10-Aug-2022
$2700
$2679.99 (13393.25%)
3 years 11 months 25 days ago
(10-Aug-2022)
1/2 (50%)
$2596.8 (2516.28%)
3
Buy
$25
$23.95 (2280.95%)
$30
4 years 5 months 1 days ago
(03-Mar-2022)
0/2 (0%)
$12.1 (128.17%)
What is OMIC (Singular Genomics Systems) average time for price targets to be met?
Which analyst has the current highest performing score on OMIC (Singular Genomics Systems) with a proven track record?
Which analyst has the current lower performing score on OMIC (Singular Genomics Systems) with a proven track record?
Which analyst has the most public recommendations on OMIC (Singular Genomics Systems)?
Which analyst is the currently most bullish on OMIC (Singular Genomics Systems)?
Which analyst is the currently most reserved on OMIC (Singular Genomics Systems)?